Evaluation of patient enrollment in oncology phase I clinical trials

Oncologist

Volumn 18, Issue 3, 2013, Pages 323-329

  Van Der Biessen, Diane A J ^a   Cranendonk, Merlijn A ^a   Schiavon, Gaia ^a   Van Der Holt, Bronno ^a   Wiemer, Erik A C ^a   Eskens, Ferry A L M ^a   Verweij, Jaap ^a   De Jonge, Maja J A ^a   Mathijssen, Ron H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Enrollment; Oncology; Patient; Phase I; Trial participation

Indexed keywords

ADULT; AGED; ARTICLE; DATA COLLECTION METHOD; DISEASE CLASSIFICATION; FEMALE; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC THERAPY;

ADOLESCENT; ADULT; AGED; BELGIUM; CLINICAL TRIALS AS TOPIC; HUMANS; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; NETHERLANDS; PATIENT PARTICIPATION; YOUNG ADULT;

EID: 84875419650     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0334     Document Type: Article

References (36)

1. World Health Organization. Cancer Fact Sheet No 297. Available at http://www.who.int/mediacentre/factsheets/fs297/en/index.html. Accessed November 23, 2012.
2. Meropol NJ, Weinfurt KP, Burnett CB et al. Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. J Clin Oncol 2003;21:2589-2596.
3. Miller FG, Joffe S. Benefit in phase 1 oncology trials: Therapeutic misconception or reasonable treatment option? Clin Trials 2008;5:617-623.
4. Sulmasy DP, Astrow AB, He MK et al. The culture of faith and hope: Patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer 2010;116:3702-3711.
5. Roberts TG Jr, Goulart BH, Squitieri L et al. Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 2004;292:2130-2140.
6. Townsley CA, Chan KK, Pond GR et al. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer 2006;6: 34.
7. Pinnow E, Sharma P, Parekh A et al. Increasing participation of women in early phase clinical trials approved by the FDA. Womens Health Issues 2009; 19:89-93.
8. El-Rayes BF, Jasti P, Severson RK et al. Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trials. Pancreas 2010;39:967-971.
9. Zafar SF, Heilbrun LK, Vishnu P et al. Participation and survival of geriatric patients in phase I clinical trials: The Karmanos Cancer Institute (KCI) experience. J Geriatr Oncol 2011;2:18-24.
10. Fisher JA, Kalbaugh CA. Challenging assumptions about minority participation in US clinical research. Am J Public Health 2011;101:2217-2222.
11. Weinfurt KP, Castel LD, Li Y et al. The correlation between patient characteristics and expectations of benefit from phase I clinical trials. Cancer 2003;98:166-175.
12. Catt S, Langridge C, Fallowfield L et al. Reasons given by patients for participating, or not, in phase 1 cancer trials. Eur J Cancer 2011;47:1490-1497.
13. Craft BS, Kurzrock R, Lei X et al. The changing face of phase 1 cancer clinical trials: New challenges in study requirements. Cancer 2009;115:1592-1597.
14. Daugherty C, Ratain MJ, Grochowski E et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 1995;13:1062-1072.
15. Itoh K, Sasaki Y, Fujii H et al. Patients in phase I trials of anti-cancer agents in Japan: Motivation, comprehension and expectations. Br J Cancer 1997; 76:107-113.
16. Nurgat ZA, Craig W, Campbell NC et al. Patient motivations surrounding participation in phase I and phase II clinical trial of cancer chemotherapy. Br J Cancer 2005;92:1001-1005.
17. Truong TH, Weeks JC, Cook EF et al. Altruism among participants in cancer clinical trials. Clin Trials 2011;8:616-623.
18. Hutchison C. Phase I trials in cancer patients: Participants' perceptions. Eur J Cancer Care (Engl) 1998;7:15-22.
19. Kohara I, Inoue T. Searching for a way to live to the end: Decision-making process in patients considering participation in cancer phase I clinical trials. Oncol Nurs Forum 2010;37:E124-E132.
20. Cheung WY, Pond GR, Heslegrave RJ et al. The contents and readability of informed consent forms for oncology clinical trials. Am J Clin Oncol 2010;33: 387-392.
21. Wootten AC, Abbott JM, Siddons HM et al. A qualitative assessment of the experience of participating in a cancer-related clinical trial. Support Care Cancer 2011;19:49-55.
22. Zhang J, Zhang H, Yu C et al. The attitudes of oncology physicians and nurses toward phase I, II, and III cancer clinical trials. Contemp Clin Trials 2011;32: 649-653.
23. Cox K, McGarry J. Why patients don't take part in cancer clinical trials: An overview of the literature. Eur J Cancer Care (Engl) 2003;12:114-122.
24. Bergenmar M, Johansson H, Wilking N. Levels of knowledge and perceived understanding among participants in cancer clinical trials-Factors related to the informed consent procedure. Clin Trials 2011;8:77-84.
25. Bergenmar M, Molin C, Wilking N et al. Knowledge and understanding among cancer patients consenting to participate in clinical trials. Eur J Cancer 2008;44:2627-2633.
26. Edwards AL, Kenney KC. A comparison of the Thurstone and Likert techniques of attitude scale construction. J Appl Psychol 1946;30:72-83.
27. World Health Organization. Manual of International Statistical Classification of Diseases and Related Health Problems, Volume 2, 10th Revision. Geneva: World Health Organization, 2010:87-108.
28. Karavasilis V, Digue L, Arkenau T et al. Identification of factors limiting patient recruitment into phase I trials: A study from the Royal Marsden Hospital. Eur J Cancer 2008;44:978-982.
29. Ho J, Pond GR, Newman C et al. Barriers in phase I cancer clinical trials referrals and enrollment: Five-year experience at the Princess Margaret Hospital. BMC Cancer 2006;6:263.
30. Pardon K, Deschepper R, Vander Stichele R et al. Changing preferences for information and participation in the last phase of life: A longitudinal study among newly diagnosed advanced lung cancer patients. Support Care Cancer 2012;20:2473-2482.
31. Moroney J, Wheler J, Hong D et al. Phase I clinical trials in 85 patients with gynecologic cancer: The M. D. Anderson Cancer Center experience. Gynecol Oncol 2010;117:467-472.
32. Chau NG, Florescu A, Chan KK et al. Early mortality and overall survival in oncology phase I trial participants: Can we improve patient selection? BMC Cancer 2011;11:426.
33. Olmos D, A'hern RP, Marsoni S et al. Patient selection for oncology phase I trials: A multi-institutional study of prognostic factors. J Clin Oncol 2012: 30;996-1004.
34. Arkenau HT, Olmos D, Ang JE et al. 90-Days mortality rate in patients treated within the context of a phase-I trial: How should we identify patients who should not go on trial? Eur J Cancer 2008;44: 1536-1540.
35. Lara PN, Jr., Higdon R, Lim N et al. Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728-1733.
36. Castel P, Négrier S, Boissel JP. Why don't cancer patients enter clinical trials? A review. Eur J Cancer 2006;42:1744-1748.